Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Ibandronic Acid × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Gastrointestinal 1 Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 247 Lenalidomide 139 Bortezomib 138 Melphalan 106 Cyclophosphamide 105 Calcium Dobesilate 101 fludarabine phosphate 60 Whole-Body Irradiation 50 carfilzomib 49 Filgrastim 49 Granulocyte Colony-Stimulating Factor 48 Peripheral Blood Stem Cell Transplantation 47 Mycophenolic Acid 45 fludarabine 44 pomalidomide 43 ixazomib 39 daratumumab 37 Busulfan 37 Tacrolimus 36 Thalidomide 34 dexamethasone acetate 27 Stem Cell Transplantation 27 Cyclosporine 26 Antilymphocyte Serum 23 dexamethasone 21-phosphate 21 auricularum 19 Prednisone 17 plerixafor 16 belantamab mafodotin 16 Bendamustine Hydrochloride 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02739594 2016-07-22

COMPARE

Hoffmann-La Roche

Phase 3 Terminated

89 enrolled 17 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡